Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
Current Signal: SELL (auto-tracking)
1.26% $38.47
America/New_York / 28 mar 2024 @ 15:29
FUNDAMENTALS | |
---|---|
MarketCap: | 3 712.33 mill |
EPS: | 0.620 |
P/E: | 62.05 |
Earnings Date: | May 05, 2024 |
SharesOutstanding: | 96.50 mill |
Avg Daily Volume: | 0.809 mill |
RATING 2024-03-28 |
---|
S- |
Strong Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Strong Buy | |
DE: | Neutral | |
P/E: | Strong Buy | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 62.05 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 62.05 | industry: PE -4.88 |
DISCOUNTED CASH FLOW VALUE |
---|
$63.99 (66.33%) $25.52 |
Date: 2024-03-28 |
Expected Trading Range (DAY) |
---|
$ 36.90 - 40.19 ( +/- 4.27%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Schlanger David J | Sell | 2 597 | Stock Option (Right to Buy) |
2024-03-26 | Schlanger David J | Sell | 305 | Stock Option (Right to Buy) |
2024-03-25 | Schlanger David J | Buy | 2 597 | Common Stock |
2024-03-26 | Schlanger David J | Buy | 305 | Common Stock |
2024-03-25 | Schlanger David J | Sell | 2 597 | Common Stock |
INSIDER POWER |
---|
-36.48 |
Last 100 transactions |
Buy: 655 228 | Sell: 1 391 998 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $38.47 (1.26% ) |
Volume | 0.417 mill |
Avg. Vol. | 0.809 mill |
% of Avg. Vol | 51.60 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $40.32 | N/A | Active |
---|
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.